Literature DB >> 14715474

Role of astrocytes in pathogenesis of ischemic brain injury.

B Gabryel1, H I Trzeciak.   

Abstract

Astrocytes play an important role in the homeostasis of the CNS both in normal conditions and after ischemic injury. The swelling of astrocytes is observed during and several seconds after brain ischemia. Then ischemia stimulates sequential morphological and biochemical changes in glia and induces its proliferation. Reactive astrocytes demonstrate stellate morphology, increased glial fibrillary acidic protein (GFAP) immunoreactivity, increased number of mitochondria as well as elevated enzymatic and non-enzymatic antioxidant activities. Astrocytes can re-uptake and metabolize glutamate and in this way they control its extracellular concentration. The ability of astrocytes to protect neurons against the toxic action of free radicals depends on their specific energy metabolism, high glutathione level, increased antioxidant enzyme activity (catalase, superoxide dismutase, glutathione peroxidase) and overexpression of antiapoptotic bcl-2 gene. Astrocytes produce cytokines (TNF-alpha, IL-1, IL-6) involved in the initiation and maintaining of immunological response in the CNS. In astrocytes, like in neurones, ischemia induces the expression of immediate early genes: c-fos, c-jun, fos B, jun B, jun D, Krox-24, NGFI-B and others. The protein products of these genes modulate the expression of different proteins, both destructive ones and those involved in the neuroprotective processes.

Entities:  

Year:  2001        PMID: 14715474     DOI: 10.1007/bf03033192

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  134 in total

1.  Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c.

Authors:  X Liu; C N Kim; J Yang; R Jemmerson; X Wang
Journal:  Cell       Date:  1996-07-12       Impact factor: 41.582

Review 2.  Heterogeneity and functional properties of subtypes of sodium-dependent glutamate transporters in the mammalian central nervous system.

Authors:  M B Robinson; L A Dowd
Journal:  Adv Pharmacol       Date:  1997

Review 3.  Glial metallothionein.

Authors:  J K Young
Journal:  Biol Signals       Date:  1994 May-Jun

4.  Selective distribution of the NMDA-R1 glutamate receptor in astrocytes and presynaptic axon terminals in the nucleus locus coeruleus of the rat brain: an immunoelectron microscopic study.

Authors:  E J Van Bockstaele; E E Colago
Journal:  J Comp Neurol       Date:  1996-06-10       Impact factor: 3.215

5.  Enhanced superoxide dismutase-2 immunoreactivity of astrocytes and occasional neurons in amyotrophic lateral sclerosis.

Authors:  H G Blaauwgeers; J M Vianney de Jong; H W Verspaget; F M van den Berg; D Troost
Journal:  J Neurol Sci       Date:  1996-09-01       Impact factor: 3.181

6.  c-Jun is a downstream target for ceramide-activated protein phosphatase in A431 cells.

Authors:  J G Reyes; I G Robayna; P S Delgado; I H González; J Q Aguiar; F E Rosas; L F Fanjul; C M Galarreta
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

Review 7.  Evolving concepts about the role of acidosis in ischemic neuropathology.

Authors:  G C Tombaugh; R M Sapolsky
Journal:  J Neurochem       Date:  1993-09       Impact factor: 5.372

Review 8.  Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets.

Authors:  G Z Feuerstein; X Wang; F C Barone
Journal:  Ann N Y Acad Sci       Date:  1997-10-15       Impact factor: 5.691

Review 9.  A role for the arachidonic acid cascade in fast synaptic modulation: ion channels and transmitter uptake systems as target proteins.

Authors:  A Volterra; D Trotti; P Cassutti; C Tromba; R Galimberti; P Lecchi; G Racagni
Journal:  Adv Exp Med Biol       Date:  1992       Impact factor: 2.622

10.  Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart.

Authors:  R J Knight; D B Buxton
Journal:  Biochem Biophys Res Commun       Date:  1996-01-05       Impact factor: 3.575

View more
  6 in total

1.  The role of integrin alpha(v)beta (8) in neonatal hypoxic-ischemic brain injury.

Authors:  Jinhui Li; Yi Qu; Xihong Li; Deyuan Li; Fengyan Zhao; Meng Mao; Donna Ferriero; Dezhi Mu
Journal:  Neurotox Res       Date:  2009-09-23       Impact factor: 3.911

2.  The use of multi b values diffusion-weighted imaging in patients with acute stroke.

Authors:  Zhenghua Liu; Xinlan Xiao
Journal:  Neuroradiology       Date:  2013-01-19       Impact factor: 2.804

3.  Toll-like receptor 3 agonist Poly I:C protects against simulated cerebral ischemia in vitro and in vivo.

Authors:  Lin-na Pan; Wei Zhu; Cai Li; Xu-lin Xu; Lian-jun Guo; Qing Lu
Journal:  Acta Pharmacol Sin       Date:  2012-09-17       Impact factor: 6.150

4.  Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis.

Authors:  Vivienne A Russell; Robert D Oades; Rosemary Tannock; Peter R Killeen; Judith G Auerbach; Espen B Johansen; Terje Sagvolden
Journal:  Behav Brain Funct       Date:  2006-08-23       Impact factor: 3.759

5.  Cell death pathways in astrocytes with a modified model of oxygen-glucose deprivation.

Authors:  Qiaoying Huang; Rui Zhang; Liang yu Zou; Xu Cao; Xiaofan Chu
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

6.  Astrocytic Toll-like receptor 3 is associated with ischemic preconditioning-induced protection against brain ischemia in rodents.

Authors:  Lin-na Pan; Wei Zhu; Yang Li; Xu-lin Xu; Lian-jun Guo; Qing Lu; Jian Wang
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.